This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kremastinos, D. T. Articles by Stavropoulos-Giokas, C. G. Search for Related Content PubMed PubMed Citation Articles by Kremastinos, D. T. Articles by Stavropoulos-Giokas, C. G. Related Collections Clinical genetics Other heart failure

(Circulation. 1999;100:2074-2078.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

Association of Heart Failure in Homozygous ß-Thalassemia With the Major Histocompatibility Complex

Dimitrios T. Kremastinos, MD; Panagiota Flevari, MD; Maria Spyropoulou, MD; Helen Vrettou, MD; Dimitrios Tsiapras, MD; Catherine G. Stavropoulos-Giokas, MD

From the 2nd Department of Cardiology (D.T.K., P.F., H.V., D.T.), Onassis Cardiac Surgery Center, and the Department of Immunology & National Tissue Typing Center (M.S., C.G.S.-G.), Athens General Hospital, Athens, Greece.

Correspondence to Dimitrios T. Kremastinos, MD, Onassis Cardiac Surgery Center, 356 Sygrou Ave, 17674 Athens, Greece. E-mail elbee{at}ath.forthnet.gr

Background—In ß-thalassemia major, heart failure primarily affecting left ventricular systolic function is the most common complication and cause of death. Apart from iron deposition, it has been recently reported that myocarditis might be another contributing factor in the pathogenesis of acute or chronic heart failure, acting possibly through an autoimmune mechanism. In an attempt to assess the role of immunogenetic factors in the development of heart failure associated with ß-thalassemia major, we studied the frequency of major histocompatibility antigens/alleles A, B, DR, and DQ in homozygous ß-thalassemic patients with and without heart failure primarily affecting the left ventricle.

Methods and Results—Forty-five consecutive unrelated Greek patients with homozygous ß-thalassemia and left-sided chronic heart failure were studied. Fifty-eight unrelated Greek patients with homozygous ß-thalassemia without heart failure and 130 unrelated Greek healthy controls were also studied. In all subjects, class I HLA-A and -B typing was performed by the complement-mediated lymphocytotoxicity assay, whereas class II HLA-DR and -DQ typing was performed by polymerase chain reaction. HLA-DRB1*1401 allele frequency was significantly increased in patients with ß-thalassemia major without left-sided heart failure compared with those with heart failure (corrected P [P_c]=0.02, odds ratio 0.1) and healthy controls (P_c=0.001). HLA-DQA1*0501 allele frequency was increased in patients with heart failure compared with patients without heart failure (P_c=0.04, odds ratio 14) and healthy controls (P_c=0.004).

Conclusions—Differences exist in the immunogenetic profile between homozygous ß-thalassemic patients with and without left-sided heart failure, raising the possibility that genetically defined immune mechanisms may play an important role in the pathogenesis of heart failure in ß-thalassemia.

Key Words: genetics • heart failure • immune system • cardiomyopathy

This article has been cited by other articles:

				D. Th. Kremastinos, D. P. Tsiapras, A. G. Kostopoulou, E. S. Hamodraka, A. S. Chaidaroglou, and E. D. Kapsali NT-proBNP levels and diastolic dysfunction in {beta}-Thalassaemia major patients Eur J Heart Fail, May 1, 2007; 9(5): 531 - 536. [Abstract] [Full Text] [PDF]

				G Bosi, R Crepaz, M R Gamberini, M Fortini, S Scarcia, E Bonsante, W Pitscheider, and M Vaccari Left ventricular remodelling, and systolic and diastolic function in young adults with {beta} thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data Heart, July 1, 2003; 89(7): 762 - 766. [Abstract] [Full Text] [PDF]

				Y.F. Cheung, G. C.F. Chan, and S.Y. Ha Arterial Stiffness and Endothelial Function in Patients With {beta}-Thalassemia Major Circulation, November 12, 2002; 106(20): 2561 - 2566. [Abstract] [Full Text] [PDF]

				M. Vaccari, R. Crepaz, M. Fortini, M. R. Gamberini, S. Scarcia, W. Pitscheider, and G. Bosi Left Ventricular Remodeling, Systolic Function, and Diastolic Function in Young Adults With {beta}-Thalassemia Intermedia : A Doppler Echocardiography Study Chest, February 1, 2002; 121(2): 506 - 512. [Abstract] [Full Text] [PDF]

				G. Hahalis, A.S. Manolis, D. Apostolopoulos, D. Alexopoulos, A.G. Vagenakis, and N.C. Zoumbos Right ventricular cardiomyopathy in {beta}-thalassaemia major Eur. Heart J., January 2, 2002; 23(2): 147 - 156. [Abstract] [Full Text] [PDF]

				L.J. Anderson, S. Holden, B. Davis, E. Prescott, C.C. Charrier, N.H. Bunce, D.N. Firmin, B. Wonke, J. Porter, J.M. Walker, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload Eur. Heart J., December 1, 2001; 22(23): 2171 - 2179. [Abstract] [PDF]